Maruishi Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Maruishi Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10789
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Maruishi Pharmaceutical Co Ltd (Maruishi) is a pharmaceutical company that develops and sells medical drugs. The company offers products in the fields of perioperative and infection control. Its products include anesthetics, perioperative drugs, pharmacopoeia drugs, and disinfectants and antiseptics. Maruishi carries out research and development and sales promotional activities for anesthetics and perioperative drugs. The company also conducts structural analysis and synthetic studies of various metabolite and degradant products. It provides physicochemical studies and formulation design through its laboratories. The company has operations in Japan, the US and China. Maruishi is headquartered in Osaka, Japan.

Maruishi Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maruishi Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Maruishi Pharma to Acquire Five Injectable Brands from Ono Pharma 11
Partnerships 12
Daiichi Sankyo Enters into Agreement with Maruishi Pharma 12
Licensing Agreements 13
Maruishi Pharma Enters into Licensing Agreement with Sumitomo Dainippon Pharma 13
Cara Therapeutics Enters Into Licensing Agreement With Maruishi Pharma For CR845 14
Maruishi Pharmaceutical Co Ltd – Key Competitors 16
Maruishi Pharmaceutical Co Ltd – Key Employees 17
Maruishi Pharmaceutical Co Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maruishi Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Maruishi Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Maruishi Pharma to Acquire Five Injectable Brands from Ono Pharma 11
Daiichi Sankyo Enters into Agreement with Maruishi Pharma 12
Maruishi Pharma Enters into Licensing Agreement with Sumitomo Dainippon Pharma 13
Cara Therapeutics Enters Into Licensing Agreement With Maruishi Pharma For CR845 14
Maruishi Pharmaceutical Co Ltd, Key Competitors 16
Maruishi Pharmaceutical Co Ltd, Key Employees 17
Maruishi Pharmaceutical Co Ltd, Other Locations 18
Maruishi Pharmaceutical Co Ltd, Subsidiaries 18

List of Figures
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maruishi Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Maruishi Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asahi Tec Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Asahi Tec Corporation Mergers a …
  • Tayside Flow Technologies Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tayside Flow Technologies Limit …
  • Solaris d.d.:企業の戦略・SWOT・財務情報
    Solaris d.d. - Strategy, SWOT and Corporate Finance Report Summary Solaris d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Acelity Holdings, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Acelity Holdings Inc (Acelity) is a medical technology company engaged in developing wound care and regenerative medicine solutions. The company offers various solutions such as incision management, open abdomen management, epidermal harvesting and animal health. Acelity through its subsidia …
  • AMCON Distributing Company:企業の戦略・SWOT・財務情報
    AMCON Distributing Company - Strategy, SWOT and Corporate Finance Report Summary AMCON Distributing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Park City Group, Inc. (PCYG):企業財務及び戦略的SWOT分析
    Summary Park City Group, Inc. (Park City Group) is a technology company that offers technology solutions and services to retailers, suppliers and brokers. The company’s retailers solutions include improve working capital, reduce inventory and shrink, improve service, and category analysis, out-of-st …
  • Akcansa Cimento Sanayi ve Ticaret AS:企業の戦略・SWOT・財務情報
    Akcansa Cimento Sanayi ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Akcansa Cimento Sanayi ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Phynova Group plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Phynova Group plc Mergers and A …
  • Monro Muffler Brake, Inc. (MNRO):企業概要、財務及び戦略的SWOT分析
    Summary Monro Muffler Brake, Inc. (Monro) is an automotive service provider. The company operates stores which provide automotive undercar repair and tire services and other related services in 19 states across the US. The company provides services to passenger cars, vans and light trucks. Monro’s b …
  • Mocon Inc. (MOCO):企業概要、財務及び戦略的SWOT分析
    Summary MOCON, Inc. (Mocon) is a provider of gas analysis products. The company develops and manufactures instruments for analyzing seal strength thresholds in rigid, semi-rigid, flexible and blister packages. It provides laboratory instruments, field instruments and testing and consulting services …
  • GlaxoSmithKline Plc (GSK):企業のM&A・提携動向(医療機器分野)
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cardiovascular, metabolic and urological diseases, immuno-in …
  • Casella Waste Systems, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Casella Waste Systems, Inc. Mer …
  • Allergan plc:企業のM&A・事業提携・投資動向
    Allergan plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allergan plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • RHÖN-KLINIKUM AG:企業の戦略・SWOT・財務分析
    SummaryRHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • The Whiting-Turner Contracting Companyの企業概要及びSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "The Whiting-Turner Contracting Company" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Worl …
  • MphasiS Limited (MPHASIS):企業の財務及び戦略的SWOT分析
    Summary MphasiS Limited (MphasiS), a subsidiary of Hewlett-Packard Company is a technology company that provides applications services, infrastructure services and business process outsourcing services. The company’s services include application development, applications management, enterprise appli …
  • EWE Aktiengesellschaft:企業のM&A・提携動向(エネルギー分野)
    Summary EWE Aktiengesellschaft (EWE) provides solution to energy, telecommunication and information technology businesses. Its business segments include generation; infrastructure; sales and trading; foreign business and IT; and central divisions/consolidation. The company’s generation segment gener …
  • Schaeffler KG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Schaeffler KG Mergers and Acqui …
  • Culver Franchising System Inc.:企業の戦略・SWOT・財務分析
    SummaryCulver Franchising System Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • KGI Securities Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' KGI Securities Co., Ltd. Merger …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆